-
Something wrong with this record ?
Increasing procoagulant activity of circulating microparticles in patients living with HIV
S. Snopkova, M. Matyskova, K. Havlickova, J. Jarkovsky, M. Svoboda, J. Zavrelova, R. Svacinka, M. Penka, P. Husa
Language English Country France
Document type Journal Article
- MeSH
- Adult MeSH
- Blood Coagulation * MeSH
- HIV Infections blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Cell-Derived Microparticles * MeSH
- Young Adult MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
OBJECTIVES: HIV-infected individuals are at higher risk of non-AIDS diseases associated with procoagulant status. Microparticles are elevated in disorders associated with thrombosis (e.g., cardiovascular diseases). We investigated the association between microparticle levels in untreated and treated HIV-infected subjects, and determined the association with immune status, viral replication, and duration of antiretroviral therapy. PATIENTS AND METHODS: We included 144 HIV-infected subjects, including 123 on antiretroviral therapy (ART) and 21 before treatment initiation. A control group of 40 HIV-negative healthy adults matched for age and sex was used for comparison of microparticle levels. Treated subjects were divided into five groups depending on the period of antiretroviral exposure. Statistically significant differences were determined by Kruskal-Wallis test and Chi2 test. The relation between microparticles and other parameters was assessed using Spearman's coefficient of correlation. RESULTS: Microparticle levels were significantly higher in treated and untreated HIV-infected subjects than in non-HIV-infected controls (P<0.001). The microparticle level was similar between the groups on treatment (P=0.913). No association between the microparticle level and CD4+ count, CD4+/CD8+ ratio, number of HIV-1 RNA copies, or duration of exposure to antiretroviral treatment was observed. CONCLUSION: Increased levels of microparticles may be due to processes independent of viral replication and CD4+ cell count, and microparticle release might persist even during viral suppression by antiretroviral treatment. Elevated microparticle levels might occur in response to other triggers.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004843
- 003
- CZ-PrNML
- 005
- 20220127144929.0
- 007
- ta
- 008
- 220113s2020 fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.medmal.2019.09.013 $2 doi
- 035 __
- $a (PubMed)31611134
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Snopkova, S $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic. Electronic address: snopkova.svatava@fnbrno.cz
- 245 10
- $a Increasing procoagulant activity of circulating microparticles in patients living with HIV / $c S. Snopkova, M. Matyskova, K. Havlickova, J. Jarkovsky, M. Svoboda, J. Zavrelova, R. Svacinka, M. Penka, P. Husa
- 520 9_
- $a OBJECTIVES: HIV-infected individuals are at higher risk of non-AIDS diseases associated with procoagulant status. Microparticles are elevated in disorders associated with thrombosis (e.g., cardiovascular diseases). We investigated the association between microparticle levels in untreated and treated HIV-infected subjects, and determined the association with immune status, viral replication, and duration of antiretroviral therapy. PATIENTS AND METHODS: We included 144 HIV-infected subjects, including 123 on antiretroviral therapy (ART) and 21 before treatment initiation. A control group of 40 HIV-negative healthy adults matched for age and sex was used for comparison of microparticle levels. Treated subjects were divided into five groups depending on the period of antiretroviral exposure. Statistically significant differences were determined by Kruskal-Wallis test and Chi2 test. The relation between microparticles and other parameters was assessed using Spearman's coefficient of correlation. RESULTS: Microparticle levels were significantly higher in treated and untreated HIV-infected subjects than in non-HIV-infected controls (P<0.001). The microparticle level was similar between the groups on treatment (P=0.913). No association between the microparticle level and CD4+ count, CD4+/CD8+ ratio, number of HIV-1 RNA copies, or duration of exposure to antiretroviral treatment was observed. CONCLUSION: Increased levels of microparticles may be due to processes independent of viral replication and CD4+ cell count, and microparticle release might persist even during viral suppression by antiretroviral treatment. Elevated microparticle levels might occur in response to other triggers.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a hemokoagulace $7 D001777
- 650 12
- $a mikropartikule $7 D055252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a HIV infekce $x krev $7 D015658
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Matyskova, M $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 700 1_
- $a Havlickova, K $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 700 1_
- $a Jarkovsky, J $u Institute of biostatistics and analyses, Faculty of medicine, Masaryk University Brno, Kamenice 126/3, 62500 Brno, Czech Republic
- 700 1_
- $a Svoboda, M $u Institute of biostatistics and analyses, Faculty of medicine, Masaryk University Brno, Kamenice 126/3, 62500 Brno, Czech Republic
- 700 1_
- $a Zavrelova, J $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 700 1_
- $a Svacinka, R $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 700 1_
- $a Penka, M $u Department of hematology, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 700 1_
- $a Husa, P $u Department of infectious diseases, Faculty hospital Brno and Faculty of medicine, Masaryk University Brno, Jihlavska 340/20, 62500 Brno, Czech Republic
- 773 0_
- $w MED00008638 $t Medecine et maladies infectieuses $x 1769-6690 $g Roč. 50, č. 7 (2020), s. 555-561
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31611134 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127144925 $b ABA008
- 999 __
- $a ok $b bmc $g 1752138 $s 1155992
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 50 $c 7 $d 555-561 $e 20191011 $i 1769-6690 $m Médecine et maladies infectieuses $n Med Mal Infect $x MED00008638
- LZP __
- $a Pubmed-20220113